STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: LinkMed’s (STO:LMED) portfolio company Likvor has received a new order for Likvor CELDA™ ,this time from Sahlgrenska University Hospital in Gothenburg. With Likvor CELDA™ the clinical will be able to dynamic measure the most important parameters concerning the patients’ cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDATM was developed to facility greater understanding and enhancing diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia. This is the third order for the instrument since it got CE marked.
